In order to investigate the role of EPHA1 in HCC angiogenesis and progression, Chen et al. [44] utilized RNA interference (RNAi) technology to downregulate EPHA1 in an HCC-derived cell line with high EPHA1 expression. The gene discussed is EPHA1; the disease is hepatocellular carcinoma.